about
Interventions for morpheaInterventions for morpheaInterventions for morpheaProgressive hemifacial atrophy: a reviewAdult outcomes of childhood-onset rheumatic diseasesCoexistent linear scleroderma and juvenile systemic lupus erythematosusJuvenile localized scleroderma: clinical and epidemiological features in 750 children. An international studyScleroderma MimickersPansclerotic morphea: A male child with hemiatrophy of lower limb.Methotrexate: an effective monotherapy for refractory generalized morpheaExtracorporeal photochemotherapy for generalized deep morphea.Is morphoea caused by Borrelia burgdorferi? A review.Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.Madarosis: a marker of many maladiesQuality of Life and Optimism in Patients with Morphea.Localized scleroderma/morphea.A case of localized scleroderma in a sculptor and his wife.Localized scleroderma: clinical spectrum and therapeutic update.United Kingdom survey of current management of juvenile localized scleroderma.Acquired facial lipoatrophy: pathogenesis and therapeutic options.Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Ocular involvement in children with localised scleroderma: a multi-centre study.Facial asymmetry: a case report of localized linear scleroderma patient with muscular strain and spasm.Update on management of connective tissue panniculitides.Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.Pseudohypertension-Like Presentation: An Exceptionally Rare Presentation in an Athletic Female Patient with Morphea.Pediatric scleroderma: systemic or localized formsDevelopment and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.Expression of selected human endogenous retroviral sequences in skin and peripheral blood mononuclear cells in morphea.Linear scleroderma as a rare cause of enophthalmos: a case report.Interleukin-17A and interleukin-23 in morphea.Targeting miR-155 to Treat Experimental SclerodermaCytokine profiles in localized scleroderma and relationship to clinical features.The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measuresMethotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center studyUpdates on morphea: role of vascular injury and advances in treatment.Scleroderma and dentistry: Two case reports.Quantitative nanohistological investigation of scleroderma: an atomic force microscopy-based approach to disease characterization.Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
P2860
Q24194241-AB6D5E9D-D593-4660-BADD-A14C62A243E8Q24200165-F23490AF-1EB1-4127-AB7F-606EB186F9F6Q24246439-8A6B9DD8-7E46-4E45-B207-5823C4A7296EQ26853037-F4DC0AD9-1E06-4FB6-8AD6-9D3286930222Q27690838-C68AAFAD-FC2E-4F3D-950E-6913BDB2538BQ28140697-126FA395-4F7A-4D24-B5AB-E69C00E3AC1BQ28287997-6ABCD4A6-ADF1-46E2-990F-E19D34FF06E7Q33625658-E549210A-8F51-4117-941B-DA728E62793EQ33647553-B2A3AE46-5C50-4FE4-ACDD-2E6EFCF8C737Q33673901-827A1CFA-3C83-4EA1-9068-38704F11B370Q33821569-983FD30E-BA9B-4DE3-A3E7-406F9A83BF27Q33904374-D487CD3A-537F-4FCD-B60F-51CC188909DDQ33919092-554C53F8-353A-4266-868B-50E06B680FE1Q34121792-3EFF12D4-1C66-45B9-A82C-4BA9187E5B26Q34277253-40906A98-1DF5-4696-B8A9-1A39A2ECFD22Q34474632-7AB85C46-29D1-490E-BE6D-1E50865C11CFQ34808389-295E84EE-FDC3-4060-8B4E-BDE4E19B113BQ34844652-8D5067E6-1121-462E-9F43-DFF171315EA5Q35070318-4D1F8666-5516-41CD-A724-076156A5ABAAQ35172344-27D582DA-0D93-4532-B21F-8A5107EA30B6Q35620537-D3B40CEC-5295-484A-B050-D567C9B1C8FAQ36009002-27A60D81-35AA-472B-A3F3-FF55F8C671BBQ36025910-D4A409AC-071D-4E89-8AA1-19C7C8FE1286Q36065381-3DE4E1FD-4010-41AB-B63C-B8CD87EADC09Q36073476-CEE10BE4-8768-4335-84D7-F499E3A4964FQ36129874-6EEC1292-9080-4C09-B1C7-EB92A748693EQ36262055-3AC609CD-486D-42A2-98B7-790DBB532FA6Q36282971-78FC1814-72CE-4548-8CCF-4B439A632796Q36401559-8BA227BA-903A-4424-991A-F383E7C5191AQ36423005-42FCAA0B-5FA0-40C3-8ED6-BFDE4EEF8640Q36426648-220AEC08-1B3A-4053-9BB8-82AD29100CC5Q36524875-D54C13E8-DC0F-4810-B514-BFB45F357188Q36524910-700E3058-D8D4-476C-A8EB-C2304CBC5DA9Q36784652-1C88BB93-7E39-4660-BE9D-160C6A6B451CQ36949289-2E2F17C3-3CB4-435D-8897-827B09186A28Q37098647-6AD040C9-760D-44B2-ACEB-B6F33C3EC2E2Q37351546-10157605-B36A-4743-A852-7878D7FCAD37Q37364181-D80E7856-187D-488A-8801-96C09C1E44A8Q37588065-3C99BC95-4FE7-4E06-A889-B8F767C913D7Q37588343-D7E5C3A3-2EAA-4E05-9A08-9DEA20CFDB3C
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Classification of morphea (localized scleroderma)
@ast
Classification of morphea (localized scleroderma)
@en
Classification of morphea (localized scleroderma)
@nl
type
label
Classification of morphea (localized scleroderma)
@ast
Classification of morphea (localized scleroderma)
@en
Classification of morphea (localized scleroderma)
@nl
prefLabel
Classification of morphea (localized scleroderma)
@ast
Classification of morphea (localized scleroderma)
@en
Classification of morphea (localized scleroderma)
@nl
P2093
P3181
P356
P1476
Classification of morphea (localized scleroderma)
@en
P2093
P304
P3181
P356
10.4065/70.11.1068
P407
P577
1995-11-01T00:00:00Z